HighTower Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-988
| Closed | -$9K | – | 3493 |
|
|
2024
Q2 | $9K | Sell |
988
-445
| -31% | -$4.05K | ﹤0.01% | 3353 |
|
|
2024
Q1 | $63K | Sell |
1,433
-450
| -24% | -$19.8K | ﹤0.01% | 3180 |
|
|
2023
Q4 | $130K | Buy |
1,883
+284
| +18% | +$19.6K | ﹤0.01% | 3103 |
|
|
2023
Q3 | $115K | Buy |
1,599
+440
| +38% | +$31.6K | ﹤0.01% | 3046 |
|
|
2023
Q2 | $87K | Sell |
1,159
-219
| -16% | -$16.4K | ﹤0.01% | 3065 |
|
|
2023
Q1 | $72K | Buy |
1,378
+196
| +17% | +$10.2K | ﹤0.01% | 2956 |
|
|
2022
Q4 | $78K | Buy |
1,182
+58
| +5% | +$3.83K | ﹤0.01% | 2926 |
|
|
2022
Q3 | $141K | Sell |
1,124
-284
| -20% | -$35.6K | ﹤0.01% | 2667 |
|
|
2022
Q2 | $133K | Buy |
1,408
+32
| +2% | +$3.02K | ﹤0.01% | 2697 |
|
|
2022
Q1 | $222K | Buy |
1,376
+595
| +76% | +$96K | ﹤0.01% | 2725 |
|
|
2021
Q4 | $260K | Sell |
781
-34
| -4% | -$11.3K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $377K | Buy |
+815
| New | +$377K | ﹤0.01% | 2257 |
|